BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15972157)

  • 1. [Advances of study on activation of nuclear factor kappaB in hematological malignancies and its mechanism--review].
    Wang GP; Qi ZH; Chen FP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):518-23. PubMed ID: 15972157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Noncanonical NF-κB pathway and hematological malignancies].
    Wang WJ; Sun AN; Guo F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1069-73. PubMed ID: 20723331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of NF-kappaB in hematopoietic malignancies - review].
    Chen C; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):954-9. PubMed ID: 18718099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated NF-kappaB activity in haematological malignancies.
    Keutgens A; Robert I; Viatour P; Chariot A
    Biochem Pharmacol; 2006 Oct; 72(9):1069-80. PubMed ID: 16854381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NF-kappaB in hematologic malignancies.
    Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
    Cell Death Differ; 2006 May; 13(5):748-58. PubMed ID: 16498458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB: a stress-regulated switch for cell survival.
    Piva R; Belardo G; Santoro MG
    Antioxid Redox Signal; 2006; 8(3-4):478-86. PubMed ID: 16677091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies.
    Panwalkar A; Verstovsek S; Giles F
    Cancer; 2004 Apr; 100(8):1578-89. PubMed ID: 15073843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importin β1 mediates nuclear factor-κB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis.
    Yan W; Li R; He J; Du J; Hou J
    Cell Signal; 2015 Apr; 27(4):851-9. PubMed ID: 25643631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
    Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
    Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.
    Turco MC; Romano MF; Petrella A; Bisogni R; Tassone P; Venuta S
    Leukemia; 2004 Jan; 18(1):11-7. PubMed ID: 14574329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NF-kappaB in lymphoid malignancies.
    Packham G
    Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of BMP Signaling and NF-κB Signaling on Osteoblastic Differentiation, Cancer Development, and Vascular Diseases--Is the Activation of NF-κB a Friend or Foe of BMP Function?
    Jimi E
    Vitam Horm; 2015; 99():145-70. PubMed ID: 26279375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP.
    Tsubaki M; Ogawa N; Takeda T; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Satou T; Nishida S
    Biomed Pharmacother; 2014 Oct; 68(8):999-1005. PubMed ID: 25443417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-κB is involved in the protocadherin-10-mediated pro-apoptotic effect in multiple myeloma.
    Li Z; Yang Z; Peng X; Li Y; Liu Q; Chen J
    Mol Med Rep; 2014 Aug; 10(2):832-8. PubMed ID: 24888369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway.
    Nishioka C; Ikezoe T; Yang J; Koeffler HP; Taguchi H
    Leukemia; 2007 May; 21(5):1044-9. PubMed ID: 17344917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation.
    Hammerman PS; Fox CJ; Cinalli RM; Xu A; Wagner JD; Lindsten T; Thompson CB
    Cancer Res; 2004 Nov; 64(22):8341-8. PubMed ID: 15548703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.